Comparative Safety of Janus Kinase Inhibitors vs Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases. uri icon

authors

  • Ahuja, Dhruv
  • Jairath, Vipul
  • Xu, Ronghui
  • Singh, Siddharth
  • Yeh, Kuan-Hung
  • Patel, Sagar B
  • Lee, Han Hee
  • Goodwin, Shane W
  • Solitano, Virginia
  • Ma, Christopher
  • Ananthakrishnan, Ashwin N
  • Namrata Singh, MD MSCI

publication date

  • July 28, 2025